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INTRODUCTION 
Oral route of drug admin istration have wide acceptance up 
to 50-60% of total dosage forms. Solid dosage forms are 
popular because of ease of administration, accurate dosage, 
self medication, pain avoidance and most importantly the 
patient compliance. The most popular dosage forms are 
being tablet and capsules, one important drawback of these 
dosage forms for some patients however is the difficu lty in 
swallowing.
1 
Drinking water plays an important role in the 
swallowing of oral dosage forms. Often times people 
experience inconvenience in swallowing conventional 
dosage forms such as tablet when water is not available in  
the case of motion sickness (kinetosis) and sudden 
episodes of coughing during the common cold, allergic 
conditions and bronchitis.
2
 For these reasons, tablet which 
can rapidly dissolve or disintegrate in the oral cavity have 
attracted a great deal of attention. Rapidly dissolving or 
disintegrating tablet are not only indicated for people who 
have swallowing difficult ies, but also are ideal for active 
people.
3 
Recently Pharmaceutical industry has become 
increasingly aware of the need that elderly be considered 
as a separate and unique medicare population. Though 
geriatric patients constitute a minor proportion of the 
population, its growth rate is high and hence will have 
significant impact on development of drug delivery  
systems. Thus mouth dissolving tablet are gaining more 
demand and popularity from last few years.
4
 Mouth 
dissolving tablets are those when put on tongue, 
disintegrates instantaneously, releasing the drug, which 
dissolves or disperses in the saliva. Faster the drug into 
solution the quicker the absorption and onset at clinical 
effect. Some drugs are absorbed from the mouth, pharynx  
 
and oesophagus as the saliva passes down into the 
stomach. In such cases, bioavailability of drug is 
significantly greater than those observed from 
conventional tablet dosage form.
5 
Metoclopramide is 
chemically related to procainamide. It is a gastric hurrying 
agent; it is now a widely used antiemet ic. It has more 
permanent effect on upper G.I.T, increases gastric 
peristalsis while relaxing the pylorus and the first part of 
deuodenum. Metoclopramide is an effective antiemetic;  
acting on the CTZ, blocks apomorphine induced vomiting. 
Metoclopramide acts through both dopaminerg ic and 
serotonergic receptors. Metoclopramide is rapidly  
absorbed orally, enters brain, crosses placenta and is 
secreted in milk. It is partly conjugated in liver and 
excreted in urine within 24 hours. Half life of 
Metoclopramide is 3-6 hours. Orally it acts in 30 m -1 h, 
but within 10 m after I.M. and 2 m after I.V. injection and 
lasts upto 4-6 h. It hastens the absorption of many drugs, 
e.g. Aspirin, Diazepam etc. by facilitating gastric 
emptying.
6 
The principle of the present investigation is to 
develop and characterize rap idly disintegrating tablets, 
which disintegrates in the oral cavity in a matter of second 
without the need of water. This helps in easy swallowing 
thereby improved clin ical effects through pregastric 
absorption, leading to an increase in bioavailability of the 
drug and quick onset of pharmacological action can take 
place. 
 
MATERIALS AND METHODS  
Metoclopramide hydrochloride was a gift from Cosme 
Pharmaceuticals., Goa. Sodium Starch Glycolate, 
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Microcrystalline cellu lose and L-HPC was a kind gift  
sample from Kawaralal and Company, Mumbai, Reliance 
Cellu lose Products & Aristo Pharmaceuticals Ltd., and 
Bhopal respectively. A ll other chemicals purchased from 
S.D Fine Chemicals, Mumbai, were of analytical reagent 
grade. 
Preparation of Metoclopramide Hydrochloride Rapidly 
Disintegrating Tablets by Mass Extrusion Technique
 7
: 
The drug is mixed with powdered Eudragit E-100 in a 
suitable ratio. Then 10% ethanol is added to the above 
mixture in a glass beaker. The consistency of the above 
solution is reduced to get gel type of preparation, and then 
it is extruded through a syringe on clean glass slab. After 
extrusion of the gel, dried overnight till ethanol is 
evaporated and solidified material (gel) crushed into 
granules using a mortar. The granules are passed through a 
sieve and collected, blend with Avicel PH 102, L-HPC, 
sodium starch glycolate, lactose, magnesium stearate and 
talc as in Table 1. Then b lend is subjected for tablet 
formulat ion. 
Table 1:  Composition of rapid ly disintegrating tablets of Metoclopramide Hydrochloride 
Ingredients (mgs) 
Formulation code 
F1 F2 F3 F4 F5 F6 F7 F8 F9 
 Metoclopramide Hcl 
Sodium starch glycolate 
Avicel PH 102 
Low hydroxyl propyl cellulose 
Eudragit E-100 
Lactose 
Magnesium stearate 
Talc 
10 
15 
-- 
-- 
10 
259 
3 
3 
10 
22.5 
-- 
-- 
10 
251.5 
3 
3 
10 
30 
-- 
-- 
10 
244 
3 
3 
10 
-- 
15 
-- 
10 
259 
3 
3 
10 
-- 
22.5 
-- 
10 
251.5 
3 
3 
10 
-- 
30 
-- 
10 
244 
3 
3 
10 
-- 
-- 
15 
10 
259 
3 
3 
10 
-- 
-- 
22.5 
10 
251.5 
3 
3 
10 
-- 
-- 
30 
10 
244 
3 
3 
 
Physical Evaluation of Metoclopramide Hydrochloride 
Rapidly Disintegrating Tablets: 
The frictional forces in a loose powder or granules can be 
measured by the angle of repose.  This is the maximum 
angle possible between the surface of a pile of powder or 
granules and the horizontal plane. The granules were 
allowed to flow through the funnel fixed to a stand at 
definite height. The angle of repose was then calculated by 
measuring the height and radius of the heap of granules 
formed. Percent compressibility of powder mix was 
determined by Carr’s compressibility index calculated by 
following equation
8
. Carr’s Index %= 100 (TBD-
LBD)/TBD, where TBD and LBD are the Tapped bulk 
density and Loosed bulk density respectively. 
Uncoated tablets were examined under a lens for the shape 
of the tablet and color was observed by keeping the tablets 
in light. Three tablets were picked from each formulat ion 
randomly and thickness was measured individually. The 
tablet thickness was measured using dial-caliper 
(Mitutoyo, Japan). Hardness indicates the ability of a tablet  
to withstand mechanical shocks while handling.  The 
hardness of the tablets was determined using Monsanto 
hardness tester
9
.  Three tablets were randomly  picked and 
hardness of the tablets from each formulation was 
determined. The friab ility of tablets was determined using 
Roche Friabilator.  
Drug content was calculated by weighing & crushing one 
tablet.  The whole amount of powdered tablet was 
transferred into a 100 ml vo lumetric flask.  Add 0.1N HCl 
up to the mark.  After few minutes the solution was 
filtered; rejecting first few ml of the filtrate. 2ml o f filtrate 
was taken in a 25 ml volumetric flask and diluted up to the 
mark with 0.1N HCl and analyzed spectrophotometrically  
at 305 nm.  The concentration of Metoclopramide 
hydrochloride (in g/ml) was calcu lated by using the 
standard calibration curve of Metoclopramide 
hydrochloride. Drug content claim was 10mg per tablet.  
This procedure was followed for 5 tablets from each 
formulat ion.   
Following method was applied to measure tablet-wetting 
time.  A piece of tissue paper folded twice was placed in a 
small petridish (i.d. = 6.5 cm) containing 6 ml of water, a  
tablet was put on the paper, and the time for complete 
wetting was measured.  Three trials for each batch were 
performed and standard deviation was also determined. A 
piece of tissue paper folded twice was placed in a s mall 
Petrid ish containing 6ml of distilled water. A tablet was 
put on the paper and time required for complete wetting 
was measured. The wetted tablet was then weighed. Water 
absorption ratio, R, was determined using equation
10
 R = 
100 x (Wa – Wb)/Wb Where, Wb = weight of the tablet 
before water absorption and Wa = weight of the tablet after 
water absorption respectively.  
In vitro dispersion time was measured by dropping a tablet 
in a measuring cylinder containing 6 ml of pH 6.8 
(simulated saliva flu id). Three tablets from each 
formulat ion were randomly selected and in vitro dispersion 
time was performed.  Standard deviation was also 
determined and it is expressed in seconds
11
.   
The process of breakdown of a tablet into smaller particles 
is called as disintegration.  The in vitro disintegration time 
of a tablet was determined using disintegration test 
apparatus as per I.P. specificat ions. In vitro release studies 
were carried out using tablet dissolution test apparatus 
USP XXIII
12
.  The purpose of stability testing is to provide 
evidence on how the quality of a drug substance or drug 
product varies with time under the influence of a variety of 
environmental factors such as temperature, humid ity and 
light, and enables recommended storage conditions, re-test 
periods and shelf lives to be established. In the present 
study, stability studies were carried out at 25
o
 / 60 % RH 
and 40
o
 / 75 % RH for a specific time period up to 30 days 
for selected formulat ions
13
. 
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RES ULTS AND DISCUSS ION 
The values for angle of repose were found to be in the 
range of 25
0
.22' to 30
0
.17'. A ll fo rmulat ions showed the 
angle of repose within 30
0
. This percent compressibility of 
powder mix was determined by Carr's compressibility 
index. The percent compressibility for all the nine 
formulat ions lies within the range of 12.676 to 17.808. All 
formulat ions are showing good compressibility. Randomly  
picked tablets from each formulation batch examined 
under lens for shape and in presence of light for co lor. 
Tablets showed flat, circu lar shape in white color.  
The thickness of the tablets was measured by using dial 
caliper by picking the tablets randomly. The values are 
almost uniform in all formulations. Thickness was found in 
the range from 2.90 mm to 3.18 mm respectively. The 
results of hardness are given in Table 2. Hardness test was 
performed by Monsanto tester. Hardness was maintained 
to be within 2.90 kg/cm
2
 to 4.16 kg/cm
2
, as these tablets 
are rapidly disintegrating. The lower standard deviation 
values indicated that the hardness of all the formulations 
were almost uniform and possess good mechanical 
strength with sufficient hardness. The percentage weight 
variation for all the formulat ion is tabulated in Table 2. All 
the tablets passed weight variation test as the % weight 
variation was within the pharmacopoeial limits of  7.5%. 
It was found to be from 298.6 to 301.0 mg. The weight of 
all the tablets was found to be uniform. The content 
uniformity was performed for all the nine formulat ions and 
results are shown in Table 2. 
Table 2: Evaluation of tablet parameters  
Formulation 
Code 
Uniformity of Thickness 
(n=3) (mm) 
Hardness (n=3) 
(kg/cm3) 
% Friability 
(n=10) 
Weight Variation 
(n=10) (mg) 
Drug Content (n=3)  
(mg) 
F1 
F2 
 F3 
 F4 
 F5 
 F6 
 F7 
F8 
 F9 
3.13 0.05 
3.17 0.06 
3.18 0.05 
2.97 0.03 
3.13 0.05 
3.15 0.13 
2.90 0.05 
2.97 0.03 
2.98 0.03 
3.87 0.29 
3.76 0.29 
3.70 0.29 
3.76 0.29 
3.24 0.29 
3.66 0.29 
3.24 0.29 
2.96 0.29 
2.90 0.29 
0.3633 
0.2103 
0.1356 
0.3496 
0.3035 
0.2103 
0.4739 
0.4200 
0.4187 
301.0 2.013 
300.5 2.153 
300.5 2.652 
298.6 2.88 
300.0 1.032 
300.1 1.272 
300.1 2.171 
299.4 3.045 
299.6 2.197 
9.790 0.148 
9.825 0.113 
9.925 0.067 
9.889 0.176 
9.900 0.031 
9.918 0.021 
9.700 0.148 
9.835 0.113 
9.876 0.054 
 
 Five trials from each formulat ion were analyzed  
spectrophotometrically. The mean value and standard 
deviation of all the formulations were calculated. The drug 
content of the tablets were found between 9.700  0.148 
mg to 9.925  0.067 mg of metoclopramide hydrochloride. 
The results indicated that in all the formulations the drug 
content was uniform. The cumulative percentage drug 
released by each tablet in the in vitro release studies were 
based on the mean content of the drug present in the 
respective tablet.  
The internal structure of tablets that is pore size 
distribution, water penetration into tablets and swelling of 
disintegration substance are suggested to be the 
mechanis m of disintegration. This was determined as per 
I.P. for all the formulations. All formulat ions showed 
disintegration time less than 25 seconds. Sodium starch 
glycolate disintegrates faster (8sec) as compared to other 
superdisintegrants. Wetting is closely related to inner 
structure of tablets. The record of the wetting time was 
shown in Table 3. The wetting time in  all the fo rmulat ion 
was very fast. This may be due to ability of swelling and 
also capacity of absorption of water. Sodium starch 
glycolate is having high water absorption capacity and 
cause swelling. SSG and MCC absorb water rapid ly in the 
formulat ions and shows fast wetting time. This parameter 
also duplicates disintegration time in oral cav ity as tablet is 
kept motionless on tongue; hence correlation between 
wetting time and disintegration time in oral cavity can also 
be made. The water absorption ratio results are tabulated in 
Table 3
Table 3:  Wetting time, water absorption ratio 
Formulation Code 
Wetting Time (n=3) 
Water Absorption Ratio 
(n=3) 
Mean  SD Mean  SD 
F1 
F2 
F3 
F4 
F5 
F6 
F7 
F8 
F9 
22.00  1.12  
18.00  0.67 
17.33  1.55 
24.67  0.36  
23.67  0.55  
22.33  1.57  
28.33  0.59  
26.00  1.01  
25.33  0.59 
27.81  1.123 
19.84  0.663 
18.45  2.135  
30.89  1.637 
29.89  1.653 
28.08  1.428 
37.89  1.345 
36.37  1.965 
34.09  1.936 
 
The ratio values of formulat ions found in the range of 
18.45 to 37.89. In this, as L-HPC quantity decreases, the 
water absorption also decreases due to less swelling 
property. In vitro dispersion time is measured by the time 
taken to undergo uniform dispersion. Rapid dispersion 
within  25 seconds observed in all the formulations. This 
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indicates the Sodium starch glycolate showed best 
disintegrant in the prepared tablets  as compared to Avicel 
PH 102 and L-HPC. This in vitro dispersion time gives 
direct information regard ing super-disintegrating nature of 
disintegrants used. 
All the n ine formulations were subjected for the in vitro 
dissolution studies using tablet dissolution tester USP 
XXIII. The samples were withdrawn at different time 
intervals and analyzed at 305 nm. Cumulative drug release 
and cumulative % drug retained were calcu lated on the 
basis of mean amount of metoclopramide hydrochloride 
present in the respective tablet. Formulation F1, F2, F3, 
releases 89.83%, 91.10%, 96.20%, respectively, at end of 
15 minutes. The rapid drug dissolution was observed in F4, 
F5, and F6, which release 85.11%, 88.71% and 90.44% 
respectively at end of 15 minutes. Formulat ion F7, F8, F9, 
releases 78.26%, 82.26%, 85.31%, respectively, at end of 
15 minutes. This rapid dissolution might be due to fast 
breakdown of particles and rapid absorption of drug. The 
drug release was completely achieved in a shorter duration 
of time. In all the formulat ions the drug release was near to 
90% within 15 minutes shown in Table 4 
Table 4: In vitro disintegration time, in vitro dispersion time 
Formulation 
Code 
 
In vitro Disintegration 
Time (Sec)(n=3) 
In vitro Dispersion 
Time (sec.) (n=3) 
 
F1 
F2 
F3 
F4 
F5 
F6 
 F7 
F8 
F9 
11.67  2.082 
09.33  1.143 
08.00  1.023 
19.30  0.556 
18.33  0.567 
16.33  0.587 
23.67  0.556 
19.33  0.545 
17.33  0.567 
20.00  1.11 
18.33  0.56 
14.33  1.24 
21.67  0.65 
19.67  0.67 
15.33  1.25 
23.67  1.23 
21.67  0.65 
20.00  1.11 
 
High d issolution may also occur due to faster breakdown. 
F4, F5, F6, F7, F8 and F9 showed release variat ion 
probably due to slow breakdown of particles. In  
comparative study for the formulat ions F3, F6, F9 releases 
96.20%, 90.44%, 85.31% respectively at the end of 15 
minutes, and graphical representation is shown in figure 1.  
 
 
Figure 1: Comparative in vitro Release Profile of Metoclopramide Rapidly Disintegrating Tablets for Formulation F -3, F-6 
& F-9.release profile of formulation F-3 containing 10% w/w SSG (    ),of fo rmulat ion F-6 containing 10% w/w MCC        
(       ), of formulation F-9 containing 10% w/w L-HPC (        ). 
Next, the model fitting of the release profiles were 
performed using PCP DISSO-V2 software to observe the 
mechanis m. The correlat ion coefficient values obtained for 
F3, F6, and F9 formulations shows Hixson Crowell model 
which are shown in figure 2.  
The formulations F3, F6, F9 were selected for stability 
studies on the basis of their high cumulative % drug 
release and also results of in vitro disintegration time, 
wetting time, and in vitro dispersion studies.
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Figure 2: Comparative in vitro Release Profile of Metoclopramide Rapidly Disintegrating Tablets According Hixson 
Crowell Equation for Formulation F-3, F-6 & F-9. release profile of formulation F-3 containing 10%w/w SSG(          ), of 
formulat ion F-6 containing 10% w/w MCC (         ), o f formulat ion F-9 containing 10% w/w L-HPC (          ). 
The stability studies were carried out at 25°/ 60% RH and 
40°/ 75% RH for all the selected formulations up to 30 
days. For every 10 d time interval the tablets were 
analyzed for drug content uniformity, hardness, in vitro  
disintegration time, friability and wetting time up to 30 d.  
These formulations showed not much variation in any 
parameter. From these results it was  revealed that, 
formulat ions F3, F6, F9 are stable and retained their 
original properties. 
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